CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Compounded Topical Diclofenac for the Treatment of Inflammation in Adults: Clinical Effectiveness, Cost-Effectiveness and Guidelines

Last updated: November 8, 2017
Project Number: RB1159-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of prescription-strength compounded topical diclofenac for the treatment of adults with inflammation?
  2. What is the cost-effectiveness of prescription-strength compounded topical diclofenac for the treatment of adults with inflammation?
  3. What are the evidence-based guidelines regarding the use of topical diclofenac for the treatment of adults with inflammation?

Key Message

No relevant literature was identified regarding the use of prescription-strength compounded topical diclofenac for the treatment of adults with inflammation.